Search

everythinglearnresearchcommunity

for

Search:↓

The p.P25L mutation in the KRT5 gene causes a rare skin condition that worsens over time and may lead to hair loss starting in young adulthood.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Tofacitinib may help treat hair loss in children with alopecia areata.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

Etretinate treatment changed hair growth patterns in many patients.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Upadacitinib improved multiple immune-related conditions in one patient.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

UTX is important for skin health and its loss can lead to skin issues, especially in females.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.